Pharmaceutical Preparations · DE · CIK 1625297
Indivior Pharmaceuticals develops and markets addiction treatment and mental health products
Comparable business profile · signals at a glance
In the 90 days to Mar 13, 2026: 6 insiders bought $204K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Ryan BarbaraDirector | Buy | 8 | $31.09 | $249 |
| Mar 9, 2026 | Ryan BarbaraDirector | Buy | 31 | $32.56 | $1K |
| Mar 6, 2026 | Kingsley Stuart ADirector | Buy | 940 | $31.87 | $30K |
| Jan 5, 2026 | Wheadon David E.Director | Buy | 1,771 | $35.39 | $63K |
| Jan 5, 2026 | Humphreys KeithDirector | Buy | 775 | $35.39 | $27K |
| Jan 5, 2026 | Ninivaggi Daniel ADirector | Buy | 775 | $35.39 | $27K |
| Jan 5, 2026 | Stejbach MarkDirector | Buy | 775 | $35.39 | $27K |
| Jan 5, 2026 | Ryan BarbaraDirector | Buy | 775 | $35.39 | $27K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.